Clinical Trials Browser

Phase 2 × hetrombopag × 30 days × Clear all

NCT05394285 2026-04-06

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT07492693 2026-03-25

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Phase 2 Recruiting

Classical hematologyGastrointestinal

Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors